Brief: Relief's Partner Acer Therapeutics Plans NDA Submission For Acer-001 In Q3 2021

MindMaze Therapeutics Holding SA

25/05/2021 06:11

May 25 (Reuters) - RELIEF THERAPEUTICS HOLDING SA  RLFB.S :
    * RELIEF'S PARTNER ACER THERAPEUTICS PLANS NDA SUBMISSION
FOR
ACER-001 IN Q3 2021 FOLLOWING PRE-NDA MEETING WITH FDA
    * ACER-001 IS BEING DEVELOPED IN COLLABORATION WITH RELIEF

Source text for Eikon:  ID:nEQ73PlQba 
Further company coverage:  RLFB.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))